Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The iscom antigen-presenting system.

B Morein1

  • 1Department of Virology, National Veterinary Institute, Uppsala, Sweden.

Nature
|March 17, 1988
PubMed
Summary
This summary is machine-generated.

Immunostimulating complexes (ISCOMs) are effective for presenting antigens to the immune system. This technology is advancing vaccine development for influenza, hepatitis B, and AIDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the humoral immune response to a multicomponent recombinant vaccine against S. aureus in healthy pregnant heifers.

Veterinary journal (London, England : 1997)·2018
Same author

Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.

Veterinary immunology and immunopathology·2014
Same author

The ISCOM: an immunostimulating complex.

Immunology today·2014
Same author

Immune responsiveness in the neonatal period.

Journal of comparative pathology·2007
Same author

Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.

Journal of medical virology·2007
Same author

Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Clinical and experimental immunology·2004
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Same journal

Dementia risk in middle-aged people linked to a blood protein.

Nature·2026
Same journal

Daily briefing: What's really happening with trust in science.

Nature·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • The immune system requires effective antigen presentation for robust vaccine responses.
  • Traditional vaccine delivery methods face challenges in eliciting strong and specific immunity.

Purpose of the Study:

  • To highlight the utility of immunostimulating complexes (ISCOMs) as a platform for antigen delivery.
  • To discuss the potential of ISCOMs in the development of novel vaccines.

Main Methods:

  • ISCOMs are utilized as a delivery system for antigens.
  • The immune system's response to ISCOM-presented antigens is evaluated.

Main Results:

  • ISCOMs demonstrate efficacy in presenting antigens to the immune system.

Related Experiment Videos

  • This approach shows promise for generating protective immune responses.

    • Conclusions:

    • Immunostimulating complexes represent a significant advancement in vaccine technology.
    • ISCOM-based vaccines are under development for influenza, hepatitis B, and AIDS.